Table 2 Brain tumors encountered in the German Neuropathology Reference Center for Epilepsy surgery
From: Low-grade developmental and epilepsy associated brain tumors: a critical update 2020
Tumor entity | Number (%) | Location temporal | Age @ Onset | Disease Duration | Age @ Surgery |
|---|---|---|---|---|---|
GG | 886 (52.7) | 81.6% | 12,8 | 11,8 | 25,0 |
DNT | 288 (17.1) | 72.5% | 14,6 | 10,8 | 25,0 |
PA | 90 (5.4) | 65% | 14,9 | 11,9 | 24,2 |
LGNET | 62 (3.7) | 78.3% | 17,3 | 12,8 | 29,4 |
IDG | 40 (2.4) | 42.5% | 14,9 | 15,3 | 24,9 |
AG | 13 (0.8) | 53.8% | 5,0 | 14,3 | 15,8 |
MVNT | 6 (0.4) | 66.7% | 17,3 | 20,7 | 35,2 |
PGNT | 4 (0.2) | 75% | 12,0 | 1,0 | 23,3 |
Total of LEAT | 1389 (82.7) | 76.8% | 13,6 | 11,8 | 25,1 |
PXA | 41 (2.4) | 85.3% | 18,6 | 12,2 | 29,7 |
CYSTS | 34 (2) | 82.4% | 22,4 | 11,7 | 35,2 |
OLIGO | 99 (5.9) | 53.4% | 24,2 | 12,4 | 38,1 |
ASTRO | 70 (4.2) | 57.1% | 26,2 | 6,5 | 32,8 |
MEN | 24 (1.4) | 45.5% | 40,7 | 6,2 | 46,1 |
OTHER | 23 (1.4) | 52.9% | 17,1 | 9,5 | 26,8 |
Total of non-LEAT | 291 (17.3) | 61.6% | 24,2 | 10,0 | 35,1 |
Total | 1680 | 74.0% | 15,5 | 11,5 | 26,9 |